blocking-patent-doctrine

2 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
18-1289 Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al. Federal Circuit 2019-04-10 Denied Response Waived blocking-patent blocking-patent-doctrine commercial-success graham-v-john-deere long-felt-need objective-indicia objective-indicia-of-non-obviousness obviousness patent-law patent-law-doctrine-of-obviousness prior-art Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. Roxanne Laboratories, Inc., 903 F.3d 1310 (Fed. Cir. 2018), …
18-1280 Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., et al. Federal Circuit 2019-04-08 Denied Amici (5) blocking-patent-doctrine blocking-patents burden-of-proof graham-v-john-deere nonobviousness objective-indicia obviousness patent patent-law patent-obviousness pharmaceutical-innovation prior-art Under 35 U.S.C. § 103, a patent "may not be obtained . .. if the differences between the claimed invention and the prior art are such that the claimed…